• OPEN AN ACCOUNT
Indian Indices
Nifty
24,461.15 114.45
(0.47%)
Sensex
80,796.84 294.85
( 0.37%)
Bank Nifty
54,919.50 -195.85
( -0.36%)
Nifty IT
35,991.25 99.40
( 0.28%)
Global Indices
Nasdaq
41,337.14 563.18
(1.38%)
Dow Jones
5,708.24 83.10
(1.48%)
Hang Seng
36,831.70 379.40
(1.04%)
Nikkei 225
8,596.35 99.55
(1.17%)
Forex
USD-INR
84.62 -0.14
(-0.16%)
EUR-INR
95.64 -0.64
(-0.67%)
GBP-INR
112.53 -0.71
(-0.62%)
JPY-INR
0.59 -0.01
(-1.42%)

EQUITY - MARKET SCREENER

Shilpa Medicare Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
530549
INE790G01031
275.2371305
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SHILPAMED
101.56
6167.67
EPS(TTM)
Face Value()
Div & Yield %
6.21
1
0
 

Ksolves India Ltd - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Ksolves India Limited Held On May 03 2025
May 03,2025
Pursuant to the above-captioned subject kindly note that the Board of Directors of the Company at its meeting held today on Saturday May 03 2025 have inter alia considered and approved the following: 1. Audited Financial Results of the Company for the quarter and financial year ended March 31 2025. 2. Audited Consolidated Financial Results of the Company for the quarter and financial year ended March 31 2025. 3. Re-appointment of M/s MSV & Associates as the Secretarial Auditors of the company for next five financial years i.e from FY 2025-26 till the conclusion of annual general meeting to be held for FY30 subject to the approval of shareholders in the ensuing general meeting. This is for your records. Thanks and Regards Manisha Kide Company Secretary and Compliance Officer